breast cancer index Search Results


90
NSABP Foundation breast cancer index (h/i) high assay result
Breast Cancer Index (H/I) High Assay Result, supplied by NSABP Foundation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/breast cancer index (h/i) high assay result/product/NSABP Foundation
Average 90 stars, based on 1 article reviews
breast cancer index (h/i) high assay result - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
bioTheranostics breast cancer index (bci) test
Breast Cancer Index (Bci) Test, supplied by bioTheranostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/breast cancer index (bci) test/product/bioTheranostics
Average 90 stars, based on 1 article reviews
breast cancer index (bci) test - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Baidu Inc index data for breast cancer
Index Data For Breast Cancer, supplied by Baidu Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/index data for breast cancer/product/Baidu Inc
Average 90 stars, based on 1 article reviews
index data for breast cancer - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
bioTheranostics gene signature assay, homeobox/interleukin-7 ratio, breast cancer index
Gene Signature Assay, Homeobox/Interleukin 7 Ratio, Breast Cancer Index, supplied by bioTheranostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene signature assay, homeobox/interleukin-7 ratio, breast cancer index/product/bioTheranostics
Average 90 stars, based on 1 article reviews
gene signature assay, homeobox/interleukin-7 ratio, breast cancer index - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
bioTheranostics theros
Summary of commercially available, first-generation, multigene prognosticators in breast cancer.
Theros, supplied by bioTheranostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/theros/product/bioTheranostics
Average 90 stars, based on 1 article reviews
theros - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
College of American Pathologists breast cancer index (hoxb13/il17br)
Summary of commercially available, first-generation, multigene prognosticators in breast cancer.
Breast Cancer Index (Hoxb13/Il17br), supplied by College of American Pathologists, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/breast cancer index (hoxb13/il17br)/product/College of American Pathologists
Average 90 stars, based on 1 article reviews
breast cancer index (hoxb13/il17br) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
NeoGenomics breast cancer index bci
Summary of commercially available, first-generation, multigene prognosticators in breast cancer.
Breast Cancer Index Bci, supplied by NeoGenomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/breast cancer index bci/product/NeoGenomics
Average 90 stars, based on 1 article reviews
breast cancer index bci - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Eli Lilly breast cancer index
Summary of commercially available, first-generation, multigene prognosticators in breast cancer.
Breast Cancer Index, supplied by Eli Lilly, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/breast cancer index/product/Eli Lilly
Average 90 stars, based on 1 article reviews
breast cancer index - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Immunomedics inc breast cancer index
Summary of commercially available, first-generation, multigene prognosticators in breast cancer.
Breast Cancer Index, supplied by Immunomedics inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/breast cancer index/product/Immunomedics inc
Average 90 stars, based on 1 article reviews
breast cancer index - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
bioTheranostics 7 gene prognostic score breast cancer index
Summary of commercially available, first-generation, multigene prognosticators in breast cancer.
7 Gene Prognostic Score Breast Cancer Index, supplied by bioTheranostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/7 gene prognostic score breast cancer index/product/bioTheranostics
Average 90 stars, based on 1 article reviews
7 gene prognostic score breast cancer index - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Agendia BV breast cancer recurrence multivariate index assay
Summary of commercially available, first-generation, multigene prognosticators in breast cancer.
Breast Cancer Recurrence Multivariate Index Assay, supplied by Agendia BV, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/breast cancer recurrence multivariate index assay/product/Agendia BV
Average 90 stars, based on 1 article reviews
breast cancer recurrence multivariate index assay - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Summary of commercially available, first-generation, multigene prognosticators in breast cancer.

Journal: ecancermedicalscience

Article Title: The past and future of breast cancer treatment—from the papyrus to individualised treatment approaches

doi: 10.3332/ecancer.2017.746

Figure Lengend Snippet: Summary of commercially available, first-generation, multigene prognosticators in breast cancer.

Article Snippet: Currently, several of these first-generation prognostic gene signatures are clinically available: (i) Endopredict (Sividon Diagnostics, Cologne, Germany) (ii) MammaPrint (Agendia, Amsterdam, the Netherlands), (iii) MapQuant DX (Ispogen, Marseille, France), (iv) Oncotype DX (Genomic Health, CA, USA), (v) PAM50 (Nanostring Technologies, WA, USA), (vi) Theros (bioTheranostics, CA, USA), (v) ( ).

Techniques: